Albert L. Reese's Insider Trades & SAST Disclosures

Albert L. Reese's most recent trade in Lexaria Bioscience Corp was a trade of 11,000 Stock Options done . Disclosure was reported to the exchange on May 15, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2025 11,000 43,000 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2024 12,000 32,000 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 5,000 20,000 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2023 5,000 15,000 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Oct 2022 3,200 10,000 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 1.96 per share. 24 May 2022 5,000 10,917 - 2.0 9,790 common shares
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 2.01 per share. 20 May 2022 1,799 5,917 - 2.0 3,611 common shares
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 2.01 per share. 18 May 2022 1,700 2,617 - 2.0 3,414 common shares
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 2.01 per share. 18 May 2022 1,501 4,118 - 2.0 3,017 common shares
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2022 3,400 6,800 - - Stock Options
Lexaria Bioscience Corp
Albert L. Reese Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 3,400 3,400 - - Stock Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades